I agree with you. Downtrend will continue till some meaningful results come through this is the way the market treats all biotechs. But I think there is a silver lining in the fact that the partnerships are still moving forward before a read out. Got absolutely abused a few weeks ago for suggesting the same thing.
Ann: Imugene HER-Vaxx Clinical Trial Collaboration with Merck, page-73
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.001(1.85%) |
Mkt cap ! $395.2M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.4¢ | $323.7K | 5.900M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 2696423 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 2771074 | 13 |
View Market Depth
| Last trade - 10.09am 28/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |